Olivier Le Rouzic
Overview
Explore the profile of Olivier Le Rouzic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gephine S, Terce G, Brulois G, Chenivesse C, Le Rouzic O, Grosbois J
Arch Bronconeumol
. 2025 Feb;
PMID: 39893080
No abstract available.
2.
Roucoux G, Scanferla E, Delorme M, Fraticelli L, Kiakouama Maleka L, Nocent-Ejnaini C, et al.
BMJ Open Respir Res
. 2025 Jan;
12(1).
PMID: 39843356
Background: Chronic obstructive pulmonary disease (COPD) is a common treatable disease often diagnosed in patients with risk factors after a prolonged period with suggestive symptoms. Our qualitative study aimed to...
3.
Gephine S, Le Rouzic O, Peres S, Chenivesse C, Grosbois J
BMJ Open
. 2025 Jan;
15(1):e092096.
PMID: 39773805
Objectives: To evaluate the short-term and long-term benefits of adding a weekly educational session to a traditional 8-week home-based pulmonary rehabilitation (PR) programme in people with chronic obstructive pulmonary disease...
4.
Margoline E, Cailliau E, Gephine S, Fry S, Le Rouzic O, Grosbois J, et al.
Clin Exp Allergy
. 2024 Aug;
54(12):1016-1019.
PMID: 39165129
No abstract available.
5.
Pamart G, Gosset P, Le Rouzic O, Pichavant M, Poulain-Godefroy O
Int J Tryptophan Res
. 2024 Mar;
17:11786469241232871.
PMID: 38495475
The kynurenine pathway is the primary route for tryptophan catabolism and has received increasing attention as its association with inflammation and the immune system has become more apparent. This review...
6.
Chenivesse C, Gephine S, Dornbierer M, Valentin V, Le Rouzic O, Wemeau L, et al.
ERJ Open Res
. 2024 Feb;
10(1).
PMID: 38348242
Background: Our objective was to evaluate the short-, medium- and long-term benefits of home-based pulmonary rehabilitation (PR) on the physical and affective components of dyspnoea in people with fibrotic idiopathic...
7.
Le Rouzic O, Picaud M, Salvator H, Bautin N, Devillier P, Perez T
Respir Med Res
. 2024 Jan;
85:101082.
PMID: 38280281
Background: Dyspnea is a complex symptom of chronic obstructive pulmonary disease (COPD) which is not strongly correlated with lung function measures. Long-acting bronchodilators (LAB) may reduce this dyspnea, but some...
8.
Briand R, Lebouvier T, Lanvin L, Ramdane N, Skrobala E, Leroy M, et al.
Sleep Breath
. 2024 Jan;
28(3):1165-1172.
PMID: 38225442
Purpose: Sleep apnoea (SA) is associated with accelerated cognitive decline in patients with mild cognitive impairment (MCI). Treatment of SA by continuous positive airway pressure (CPAP) may slow this decline...
9.
de Broucker V, Andujar P, Wardyn P, Lepage N, Le Rouzic O, Edme J, et al.
BMJ Open Respir Res
. 2023 Sep;
10(1).
PMID: 37758668
Material And Methods: An overall 'whole working life' cumulative exposure index was calculated for occupational patients with COPD. Spirometry indices and lung volumes were measured according to the 2005 American...
10.
Gephine S, Lemyze M, Pauquet P, Le Rouzic O, Fry S, Chenivesse C, et al.
Respir Med Res
. 2023 Apr;
83:100991.
PMID: 37043972
No abstract available.